{"id":"CHEMBL1073","canonicalSmiles":"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1","inchiKey":"ZJJXGWJIGJFDTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLIPIZIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glibenese","Glipizide","Glucotrol","Glucotrol xl","Minodiab 2.5","Minodiab 5"],"synonyms":["CP-28,720","CP-28720","Glipizide","Glipizide slow release","K 4024","K-4024","NSC-759120"],"crossReferences":{"DailyMed":["glipizide"],"PubChem":["11111214","11112714","144203707","144212151","170465089","50104189","56422485","855947"],"Wikipedia":["Glipizide"],"drugbank":["DB01067"],"chEBI":["5384"]},"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0003914","EFO_0003884","MONDO_0005148","EFO_0000400"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL107316","canonicalSmiles":"COc1cc2c(cc1OC)C(=O)[C@H](CC1CCN(Cc3ccccc3)CC1)C2","inchiKey":"ADEBPBSSDYVVLD-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL107316","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07701"],"chEBI":["53292"]},"childChemblIds":["CHEMBL2448118"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076347","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1","inchiKey":"ICUTUKXCWQYESQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOCARBAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tcc soap"],"synonyms":["3,4,4'-trichlorocarbanilide","NSC-72005","TCC","Triclocarban"],"crossReferences":{"PubChem":["124892764","144205631","144209228","144210799","170465481","26757451","85148633"],"Wikipedia":["Triclocarban"],"drugbank":["DB11155"],"chEBI":["48347"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1179047","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1Cl","inchiKey":"VDANGULDQQJODZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPROCAINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["2-chloroprocaine","Chloroprocaine"],"crossReferences":{"DailyMed":["chloroprocaine%20hydrochloride"],"Wikipedia":["Chloroprocaine"],"drugbank":["DB01161"],"chEBI":["3636"]},"childChemblIds":["CHEMBL944"],"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0007202","MONDO_0005129","EFO_0003843","EFO_0002950"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 4 investigational indications."}
{"id":"CHEMBL1181633","canonicalSmiles":"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccccc2)cc1","inchiKey":"VFCNQNZNPKRXIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRILLIANT GREEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Brilliant_Green_(dye)"],"drugbank":["DB03895"],"chEBI":["44107"]},"childChemblIds":["CHEMBL1789985","CHEMBL3561225","CHEMBL186357","CHEMBL1545634"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182997","canonicalSmiles":"COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[N@@+](C)(CCCOC(=O)/C=C(\\Cl)C(=O)OCCC[N@+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2","inchiKey":"ZQLDXCSTJFLRPY-RWBXLJKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANTACURIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gantacurium cation","Gantacurium ion"],"crossReferences":{"drugbank":["DB05710"]},"childChemblIds":["CHEMBL275321"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1187011","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1","inchiKey":"YXUPZGKORWTXID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMIPHEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Domiphen","Domiphen cation","Domiphen ion","Phenododecinium"],"crossReferences":{"drugbank":["DB11594"]},"childChemblIds":["CHEMBL486696"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL1194666","canonicalSmiles":"CCN(CC)C(C)C(=O)c1ccccc1","inchiKey":"XXEPPPIWZFICOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLPROPION","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".alpha.-benzoyltriethylamine","Amfepramone","Anfepramone","Anferpramon","C06954","D07444","Diethylcathinone","Diethylpropion","J4.327C"],"crossReferences":{"DailyMed":["diethylpropion%20hydrochloride"],"Wikipedia":["Amfepramone"],"drugbank":["DB00937"],"chEBI":["4530"]},"childChemblIds":["CHEMBL1693"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0000676","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for obesity."}
{"id":"CHEMBL1200731","canonicalSmiles":"[Cl-].[K+]","inchiKey":"WCUXLLCKKVVCTQ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Diffu-k","Duro-k","K+10","K-contin","K-dur","K-dur 20","K-lease","K-tab","Kaleorid","Kaleorid lp","Kaon cl","Kaon cl-10","Kaon-Cl","Kato","Kay-cee-l","Klor-Con 10","Klor-Con 10Meq","Klor-Con 8","Klor-con","Klor-con m10","Klor-con m15","Klor-con m20","Kloref","Kloref-s","Klotrix","Leo k","Micro k","Micro-k","Micro-k 10","Micro-k ls","Nu-k","Pot chlor (pot 12mmol)","Pot chlor strong","Potassium chloride","Sando-k","Slow-k","Ten-k"],"synonyms":["B1653","Chloride (as potassium)","E 508","E-508","E508","INS NO.508","INS-508","Kali muriaticum","Kalii chloridum","NSC-77368","Neobakasal","Potassium (as chloride)","Potassium chloride","Sylvine","Sylvite"],"crossReferences":{"DailyMed":["potassium%20chloride"],"DrugCentral":["4199"],"Wikipedia":["Potassium_chloride"],"drugbank":["DB00761"],"chEBI":["32588"]},"childChemblIds":["CHEMBL2105895"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiac arrhythmia and hemorrhage and has 11 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL1200768","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)[O-].[Na+]","inchiKey":"JEEWDSDYUSEQML-ROMZVAKDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAZIDIME SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL44354","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceftazidime sodium"],"crossReferences":{"chEBI":["53675"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200803","canonicalSmiles":"O=C(O)CCC(=O)O.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1","inchiKey":"RXZMMZZRUPYENV-VROPFNGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLIFENACIN SUCCINATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1734","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Solifenacin succinate","Vesicare","Vesicare ls"],"synonyms":["Solifenacin succinate","YM-67905","YM-905","YM67905","YM905"],"crossReferences":{"DailyMed":["solifenacin%20succinate"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0003103","EFO_0006865","HP_0000020","EFO_1000781","EFO_0000284","HP_0011277"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for overactive bladder and urgency urinary incontinence and has 1 investigational indication."}
{"id":"CHEMBL1201150","canonicalSmiles":"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)CCC(=O)O","inchiKey":"PORMUFZNYQJOEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUMATRIPTAN SUCCINATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL128","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alsuma","Imigran","Imigran 50","Imigran radis","Imigran recovery","Imigran subject","Imitrex","Imitrex statdose","Migraitan","Migraleve ultra","Onzetra xsail","Sumatriptan succinate","Sumavel dosepro","Zecuity","Zembrace symtouch"],"synonyms":["GR 43175C","GR-43175C","NSC-760362","Sumatriptan (as succinate)","Sumatriptan galpharm","Sumatriptan succinate","Treximet"],"crossReferences":{"DailyMed":["sumatriptan%20succinate"],"PubChem":["49681638"],"chEBI":["64359"]},"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0100431","MONDO_0005277","HP_0002315","MONDO_0005475"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL1201441","drugType":"Small molecule","blackBoxWarning":false,"name":"COLISTIMETHATE SODIUM","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colifin 1 miu","Colifin 2 miu","Colistimethate sodium","Colobreathe","Coly-mycin","Coly-mycin m","Promixin"],"synonyms":["Colistimethate sodium","NSC-756688","W 1929"],"crossReferences":{"DailyMed":["colistimethate%20sodium"],"DrugCentral":["731"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for infection and has 4 investigational indications."}
{"id":"CHEMBL1201512","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"FOMIVIRSEN SODIUM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitravene","Vitravene preservative free"],"synonyms":["Fomivirsen eicosasodium salt","Fomivirsen na","Fomivirsen sodium","ISIS 2922","ISIS-2922"],"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for eye infection and has 1 investigational indication."}
{"id":"CHEMBL1213352","canonicalSmiles":"C#CCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"MFZOSKPPVCIFMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domar","Pinazepam"],"crossReferences":{"Wikipedia":["Pinazepam"],"drugbank":["DB13335"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1221659","canonicalSmiles":"Cc1cc(N)nc(CCNC(=O)c2ccc(C#N)cc2)c1","inchiKey":"QINCZVSBLITNRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221659","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222250","canonicalSmiles":"OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"WQZGKKKJIJFFOK-GASJEMHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capd","Clintec","Dextro energy","Dextrogel","Gambrosol","Glucose-40","Gsf-syrup","Insta-glucose","Rapilose","Yourgluco"],"synonyms":["Anhydrous dextrose","Anhydrous glucose","D-glucose, anhydrous","Dextrose","Dextrose anhydrous","Dextrose solution","Dextrose, anhydrous","Dextrose, unspecified","Dextrose, unspecified form","Glucose","Glucose anhydrous","Glucose injection","Glucose, anhydrous","Glucose, liquid","Glucose, unspecified form","Grape sugar","Liquid glucose","NSC-406891"],"crossReferences":{"DailyMed":["dextrose"],"PubChem":["144206716","144207343","29218051"],"Wikipedia":["Glucose"],"chEBI":["4167"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and varicose veins and has 47 investigational indications."}
{"id":"CHEMBL1231347","canonicalSmiles":"CCCCSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O","inchiKey":"LTSUEVPGSXUJHT-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07463"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232397","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)NP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"XZLLMTSKYYYJLH-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232397","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01965"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237025","drugType":"Enzyme","blackBoxWarning":true,"name":"PEGLOTICASE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Krystexxa","Puricase"],"synonyms":["Krystexxa","Pegloticase"],"crossReferences":{"DailyMed":["pegloticase"],"DrugCentral":["5176"],"Wikipedia":["Pegloticase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for gout and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL125200","canonicalSmiles":"Cc1cccc2c1CCNC2=O","inchiKey":"RLLZPXDJYADIEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-128763","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-128763"],"crossReferences":{"drugbank":["DB03722"],"chEBI":["41928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254766","canonicalSmiles":"CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13","inchiKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTRORPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-levorphanol","Dextro-dromoran","Dextrorphan","Ent-17-methylmorphinan-3-ol","Levorphanol d-form","RO 1-6794","RO-1-6794"],"crossReferences":{"drugbank":["DB14682"],"chEBI":["29133"]},"childChemblIds":["CHEMBL2106292","CHEMBL1426948","CHEMBL1256681"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL136800","canonicalSmiles":"O=C(c1ccc2nccnc2c1)N1CCCCC1","inchiKey":"ANDGGVOPIJEHOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CX516","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampalex","BDP 12","BDP-12","CX 516","CX-516","Cx516"],"crossReferences":{"Wikipedia":["CX-516"],"drugbank":["DB06247"],"chEBI":["34605"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1412","canonicalSmiles":"C1CNCCN1","inchiKey":"GLUUGHFHXGJENI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepar","Ascalix","Ectodyne","Expelix","Ins umuline rapide","Wormex"],"synonyms":["Piperazine"],"crossReferences":{"PubChem":["144207113","144209440","144210424","26748210"],"Wikipedia":["Piperazine"],"drugbank":["DB00592"],"chEBI":["28568"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for helminthiasis."}
{"id":"CHEMBL1466","canonicalSmiles":"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O","inchiKey":"DOBMPNYZJYQDGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICUMAROL","yearOfFirstApproval":1944,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicumarol"],"synonyms":["Bishydroxycoumarin","Dicoumarol","Dicoumarolum","Dicumarol","NSC-17860","NSC-221570","NSC-41834"],"crossReferences":{"PubChem":["11112184","144203908","170465275"],"Wikipedia":["Dicoumarol"],"drugbank":["DB00266"],"chEBI":["4513"]},"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0004419"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1944 and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL1555","canonicalSmiles":"Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2","inchiKey":"QORVDGQLPPAFRS-XPSHAMGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALANTAMINE HYDROBROMIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL659","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galantamine hydrobromide","Razadyne","Razadyne er"],"synonyms":["(-)-galantamine hydrobromide","Galantamine hydrobromide","Galanthamine hydrobromide","Jilkon hydrobromide","Lycoremine hydrobromide","Nivalin","Nivaline","Tamilin"],"crossReferences":{"DailyMed":["galantamine%20hydrobromide"],"PubChem":["26719770","49681569"]},"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","HP_0100543","Orphanet_282","EFO_0004718","HP_0000726","EFO_0000677","MONDO_0004975"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for alzheimer disease and dementia and has 5 investigational indications."}
{"id":"CHEMBL15562","canonicalSmiles":"c1cncnc1","inchiKey":"CZPWVGJYEJSRLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIMIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-89305","Pyrimidine"],"crossReferences":{"Wikipedia":["Pyrimidine"],"chEBI":["16898"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1568276","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"OCXSDHJRMYFTMA-KMFBOIRUSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFCILLIN SODIUM","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1443","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nafcillin sodium","Nallpen","Unipen"],"synonyms":["Anhydrous nafcillin sodium","NSC-757108","Nafcillin sodium","Nafcillin sodium anhydrous","Nafcillin sodium monohydrate","Nafcillin sodium salt anhydrous","Nafcillin sodium salt monohydrate","Sodium nafcillin","Sodium nafcillin monohydrate","WY-3277"],"crossReferences":{"DailyMed":["nafcillin%20sodium"],"PubChem":["11112986","144204318","170465253","56423140"],"chEBI":["51919"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL157366","canonicalSmiles":"CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)OC(COC(C)=O)COC(=O)CCCCCCCCCCCCCCC","inchiKey":"GAKUNXBDVGLOFS-DUZKARGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSEDIPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EC-18","Ec-18","Mosedipimod"],"crossReferences":{"drugbank":["DB12592"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1738889","canonicalSmiles":"C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"JNGVJMBLXIUVRD-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOBOSARM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ostarine"],"synonyms":["Enobosarm","GTX-024","Gtx-024","MK-2866"],"crossReferences":{"drugbank":["DB12078"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0009851","HP_0000020","HP_0004326","MONDO_0007254","EFO_0000305","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL17432","canonicalSmiles":"O=c1[nH]c(=O)n(COCCO)cc1Cc1ccccc1","inchiKey":"SPJAGILXQBHHSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL17432","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07437"],"chEBI":["41037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1788384","canonicalSmiles":"CC(=O)Nc1cc([As]2SCC(CO)S2)ccc1O","inchiKey":"MRUDSZSRLQAPOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARSTHINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arsthinenol","Arsthinol","Mercaptoarsenical","Mercaptoarsenol"],"crossReferences":{"drugbank":["DB08928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL181954","canonicalSmiles":"CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O","inchiKey":"OKJHGOPITGTTIM-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVEGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-519818","LY-9818","LY519818","LY9818","Ly519818","Naveglitazar"],"crossReferences":{"drugbank":["DB12662"]},"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL184","canonicalSmiles":"Nc1nc(O)c2ncn(COCCO)c2n1","inchiKey":"MKUXAQIIEYXACX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACYCLOVIR","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aciclovir","Acycloguanosine","Acyclovir","Avaclyr","Avert","Aviral","Clearsore","Cyclovir","Cymex ultra","Duvimex","Herpetad","Lipsore","Lypsyl","Ranovir","Sitavig","Soothelip","Soraway","Viralief","Virasorb","Virovir 200","Virovir 400","Virovir 800","Zovirax"],"synonyms":["Aciclovir","Aciclovirum","Acyclovir","Gerpevir","NSC-645011","NSC-758477","Novirus","Zovirax"],"crossReferences":{"DailyMed":["acyclovir","acyclovir%20sodium"],"PubChem":["11110742","11110743","124879196","144203626","170464640","174007373","26747423","50104033","50105759","50112892","855732","90341314"],"Wikipedia":["Aciclovir"],"drugbank":["DB00787"],"chEBI":["2453"]},"childChemblIds":["CHEMBL1200380"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 approved and 15 investigational indications."}
{"id":"CHEMBL186174","canonicalSmiles":"Clc1ccc(CN(Cc2ccc(Cl)cc2)c2nn[nH]n2)cc1","inchiKey":"UOUXILZUBDIWQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL186174","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817477"],"drugbank":["DB04037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1910936","canonicalSmiles":"O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21","inchiKey":"AZAANWYREOQRFB-SETSBSEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK3207","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 3207","MK-3207","Mk-3207","Mk3207"],"crossReferences":{"drugbank":["DB12424"]},"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2007641","drugType":"Antibody","blackBoxWarning":true,"name":"PERTUZUMAB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omnitarg","Omnitarg Perjeta","Perjeta"],"synonyms":["Pertuzumab","Pertuzumab-zzxf","RG-1273","RHUMAB 2C4","RHUMAB-2C4"],"crossReferences":{"DailyMed":["pertuzumab"],"DrugCentral":["4957"],"Wikipedia":["Pertuzumab"]},"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0003869","EFO_0000365","EFO_0002916","MONDO_0008170","EFO_0000478","MONDO_0007254","EFO_1000657","MONDO_0021063","MONDO_0002087","EFO_0000305","EFO_0003060","EFO_1000984","MONDO_0008315","EFO_1001951","EFO_0000311","EFO_0009708","EFO_1000307","MONDO_0001056","EFO_0000304","MONDO_0002158","EFO_1001480","EFO_0003968","EFO_0006861","MONDO_0002120","EFO_0005537"],"count":27},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104045","canonicalSmiles":"CCOCCOC(=O)/C=C/c1ccc(OC)cc1","inchiKey":"CMDKPGRTAQVGFQ-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINOXATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cinoxate"],"crossReferences":{"drugbank":["DB15467"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2104116","canonicalSmiles":"CC(CC(C)(C)O)OC(O)C(Cl)(Cl)Cl","inchiKey":"QVFWZNCVPCJQOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lora"],"synonyms":["Chloralodol","Chlorhexadol"],"crossReferences":{"drugbank":["DB01534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104234","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCOCc2ccccc2)CC1","inchiKey":"UVTBZAWTRVBTMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZETHIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9606","Benzethidin","Benzethidine","IDS-NB-001","NIH 7574","NIH-7574"],"crossReferences":{"drugbank":["DB01518"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104987","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC","inchiKey":"CILIXQOJUNDIDU-ASQIGDHWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TEDUGLUTIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gattex kit"],"synonyms":["ALX 0600","ALX-0600","Gattex","Revestive","Teduglutide","Teduglutide (rdna origin)","Teduglutide recombinant"],"crossReferences":{"chEBI":["72305"]},"linkedTargets":{"rows":["ENSG00000065325"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0003086","MONDO_0021187","EFO_0008572","EFO_0000764","EFO_0001421","MONDO_0015183","EFO_0000384","Orphanet_365563"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for short bowel syndrome and primary short bowel syndrome and has 7 investigational indications."}
{"id":"CHEMBL2105040","canonicalSmiles":"CNCC(O)c1cc(OC)c(O)c(OC)c1","inchiKey":"ZKGDBJAHIIXDDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETOFRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anassicol","Dimethophrine","Dimetofrine","Dimetrophine"],"crossReferences":{"drugbank":["DB13494"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105131","canonicalSmiles":"CN(CC1(C)CCCO1)S(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"SMNOERSLNYGGOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEFRUSIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baycaron"],"synonyms":["BAY 1500","BAY-1500","Mefruside"],"crossReferences":{"PubChem":["144206878"],"drugbank":["DB13405"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL2105456","canonicalSmiles":"CCCCC(C(=O)O)C(=O)N(Nc1ccccc1)c1ccccc1","inchiKey":"FLWFHHFTIRLFPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUMADIZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bumadizone"],"crossReferences":{"drugbank":["DB13286"],"chEBI":["76119"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105497","canonicalSmiles":"COC(CN1CCN(CC(O)C(OC)c2ccccc2)CC1)c1ccccc1","inchiKey":"VSTNNAYSCJQCQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIPEPROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zipeprol","Zo-tab"],"crossReferences":{"drugbank":["DB13564"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106167","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)CN(C1CCCCC1)C2=O","inchiKey":"VPMWFZKOWULPGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOREXOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorexolone"],"crossReferences":{"PubChem":["170466039"],"drugbank":["DB13617"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106941","canonicalSmiles":"CC(C)(C)C(=O)NNCc1ccccc1","inchiKey":"FWWDFDMCZLOXQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIVHYDRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pivalylbenzhydrazine","Pivhydrazine"],"crossReferences":{"drugbank":["DB09252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107841","drugType":"Protein","blackBoxWarning":true,"name":"ALBIGLUTIDE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eperzan"],"synonyms":["Albiglutide","Albiglutide (genetical recombination)","GSK-716155","GSK716155","Tanzeum"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0000373","MONDO_0005148","EFO_0000400"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108251","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ANTICOAGULANT HEPARIN SOLUTION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anticoagulant heparin solution"],"description":"Oligosaccharide drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108575","drugType":"Antibody","blackBoxWarning":false,"name":"ASELIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aselizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108742","drugType":"Antibody","blackBoxWarning":false,"name":"SIPLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-507","Siplizumab"],"linkedTargets":{"rows":["ENSG00000116824"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0013730","EFO_0003086","Orphanet_238510","EFO_0003884","EFO_0000574","EFO_0000676","EFO_1002048","EFO_0000311"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2108880","drugType":"Enzyme","blackBoxWarning":false,"name":"SERRAPEPTASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aniflazym"],"synonyms":["Irzaim","Serralysin","Serrapeptase","Serratiopeptidase"],"description":"Enzyme drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108895","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ALICAFORSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alicaforsen","Alicaforsen nonadecasodium salt","Alicaforsen sodium","ISIS 2302","ISIS-2302"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109540","drugType":"Antibody","blackBoxWarning":false,"name":"ALIROCUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Praluent"],"synonyms":["Alirocumab","REGN-727","REGN727","SAR-236553","SAR236553"],"crossReferences":{"DailyMed":["alirocumab"],"DrugCentral":["5016"]},"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","MP_0001845","HP_0003124","EFO_0001645","Orphanet_391665","EFO_0008583","EFO_0000319","EFO_0000400","EFO_0004911","Orphanet_309005","EFO_0004265"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL2110372","canonicalSmiles":"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl","inchiKey":"GGWBHVILAJZWKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANITIDINE HYDROCHLORIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1790041","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azantac","Dumoran","Gavilast","Gavilast-p","Histac","Raciran 150","Raciran 300","Ranicalm","Raniplex","Ranitic","Ranitidine hydrochloride","Ranitil","Rantec","Ranzac","Vivatak","Zaedoc 150","Zaedoc 300","Zantac","Zantac 150","Zantac 25","Zantac 300","Zantac 75","Zantac 75 dissolve","Zantac 75 relief","Zantac 75 relief dissolve"],"synonyms":["AH 19065","AH-19065","Ranitidine hcl","Ranitidine hydrochloride","Taladine"],"crossReferences":{"DailyMed":["ranitidine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0009454","EFO_0000764","MONDO_0043839","EFO_0004607"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2110978","canonicalSmiles":"O=S(=O)(O)CI","inchiKey":"RDFJFVXMRYVOAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIODAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methanesulfonic acid, iodo-","Methiodal"],"crossReferences":{"drugbank":["DB13321"]},"childChemblIds":["CHEMBL2106907"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL211538","canonicalSmiles":"OB1OCc2cc(Cl)ccc21","inchiKey":"HMAFTPZYFJFEHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AN-2718","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["An-2718","An2718"],"crossReferences":{"drugbank":["DB12810"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2218922","canonicalSmiles":"CN1CCC23NC(=O)CC(c4cc(Cl)ccc4O2)C3C1","inchiKey":"MJRPHRMGEKCADU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORTALAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LM-1404","Lortalamine"],"crossReferences":{"drugbank":["DB09187"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2252704","canonicalSmiles":"C[C@H]1CC=CC(=O)O1","inchiKey":"DYNKRGCMLGUEMN-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-(6S)-PARASORBIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14121"],"chEBI":["7926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233349","canonicalSmiles":"N=C1NC(=O)/C(=C/c2ccc(-c3ccc(C(=O)O)cc3)o2)S1","inchiKey":"JLRKRQCTYQGDKJ-GHXNOFRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233349","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284642","canonicalSmiles":"Cc1c[nH]c2c(O)cc3c(c12)[C@H](CCl)CN3C(=O)c1cc2cc(NC(=O)Nc3ccc4[nH]c(C(=O)N5C[C@@H](CCl)c6c5cc(O)c5[nH]cc(C)c65)cc4c3)ccc2[nH]1","inchiKey":"FONKWHRXTPJODV-DNQXCXABSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIZELESIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bizelesin","NSC-615291","U 77779","U-77779"],"crossReferences":{"PubChem":["487336"],"drugbank":["DB12352"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL284906","canonicalSmiles":"O=C(NCCO[N+](=O)[O-])c1cccnc1","inchiKey":"LBHIOVVIQHSOQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICORANDIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ikorel"],"synonyms":["Nicorandil","SG-75","Sigmart"],"crossReferences":{"PubChem":["11114278","144204519","170465582","26719873","85148372"],"Wikipedia":["Nicorandil"],"drugbank":["DB09220"],"chEBI":["31905"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 5 investigational indications."}
{"id":"CHEMBL290140","canonicalSmiles":"CNC(=O)[C@H](Cc1c(F)c(F)c(F)c(F)c1F)NC(=O)Nc1nnc(S)s1","inchiKey":"HZAXNPDJVFUGDS-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PNU-142372","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-142372"],"crossReferences":{"drugbank":["DB07988"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3092995","canonicalSmiles":"NS(=O)(=O)NC[C@H]1COc2cc(Cl)ccc2O1","inchiKey":"KXSAIQPPGSSNKX-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-26489112","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-26489112","Jnj-26489112"],"crossReferences":{"drugbank":["DB15203"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL318191","canonicalSmiles":"CC(=O)c1ccc2c(c1)[C@H](NC(=O)c1ccc(F)c(Cl)c1)[C@H](O)C(C)(C)O2","inchiKey":"XLIIRNOPGJTBJD-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TONABERSAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-220453","Tonabersat"],"crossReferences":{"drugbank":["DB06578"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544936","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-844","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xl-844"],"linkedTargets":{"rows":["ENSG00000183765","ENSG00000149554"],"count":2},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000574","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544939","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2979165","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HY-13239","LY-2979165","Ly2979165"],"linkedTargets":{"rows":["ENSG00000164082"],"count":1},"linkedDiseases":{"rows":["EFO_0000289"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545122","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](CC(C)C)C(=O)O)CSSC[C@@H](C(=O)N[C@H](C(=O)O)C(C)C)NC1=O","inchiKey":"WGEWYYPHYMGJNT-HLHYUOOASA-N","drugType":"Protein","blackBoxWarning":false,"name":"DOLCANATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dolcanatide","SP-333"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545167","drugType":"Protein","blackBoxWarning":false,"name":"FE 202767","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fe 202767"],"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3633460","canonicalSmiles":"COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O","inchiKey":"ICYNYWFGIDGBRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06282999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-06282999"],"crossReferences":{"drugbank":["DB11683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL370437","canonicalSmiles":"O=C(O)c1ccc(-c2cc(Cl)ccc2Cl)o1","inchiKey":"ATAZLMGGQQLRBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL370437","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07758"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707232","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS SUCCINATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ferromyn"],"synonyms":["CEREVON","Ferrlecit 2","Ferrous succinate","Iron succinate (fe(o4c4h4))"],"crossReferences":{"DrugCentral":["4544"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL3707253","drugType":"Antibody","blackBoxWarning":false,"name":"BEVACIZUMAB 111IN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevacizumab 111in","Bevacizumab in111"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3716552","canonicalSmiles":"COc1cc(OCc2csc(-c3ccc(C(=O)N(C)C)cc3)n2)c2cc(-c3cn4nc(OC)sc4n3)oc2c1","inchiKey":"KEEBLYWBELVGPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986141","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986141","Bms-986141","UDM-003183"],"crossReferences":{"drugbank":["DB14942"]},"linkedTargets":{"rows":["ENSG00000127533"],"count":1},"linkedDiseases":{"rows":["HP_0002140","MONDO_0000831","EFO_0001645","EFO_0001421"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL372205","canonicalSmiles":"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1","inchiKey":"NRPQELCNMADTOZ-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LECOZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lecozotan"],"crossReferences":{"drugbank":["DB12540"]},"childChemblIds":["CHEMBL2107349"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 1 investigational indication."}
{"id":"CHEMBL37858","canonicalSmiles":"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O","inchiKey":"XBHBWNFJWIASRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARAFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBOTT-57135","Sarafloxacin"],"crossReferences":{"PubChem":["174006988"],"Wikipedia":["Sarafloxacin"],"drugbank":["DB11491"]},"childChemblIds":["CHEMBL1730031","CHEMBL542157"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3979920","canonicalSmiles":"Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1","inchiKey":"MJHOMTRKVMKCNE-NWDGAFQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVAVOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mivavotinib","TAK-659F"],"childChemblIds":["CHEMBL4594253"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0001075","MONDO_0044889","EFO_0000403","EFO_0000574","EFO_0000222","MONDO_0018906","EFO_0005952"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3989481","canonicalSmiles":"C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"GTPHQORJKFJIRB-JTQLPTLWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FRAKEFAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bch-3963","Frakefamide","LEF-576","SPD-759","SPD759"],"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989573","canonicalSmiles":"CN1C(=O)CC[C@H]1c1cccnc1.CN1C(=O)CC[C@H]1c1cccnc1.O=C(O)/C=C/C(=O)O","inchiKey":"NXHGVNVRWLOZDF-SZYUIZJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COTININE FUMARATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL578211","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cotinine fumarate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989893","canonicalSmiles":"CNc1ccc(C(=O)CC(O)CCC(C)C2OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC3(O)CC(O)C(C(=O)OC)C(CC(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C2C)O3)cc1.COC(=O)C1C(O)CC2(O)CC(O)CC(O)CC(O)CC(O)CC(=O)CC(O)CC(=O)OC(C(C)CCC(O)CC(=O)c3ccc(N)cc3)C(C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)CC1O2","inchiKey":"ALPPGSBMHVCELA-WHUUVLPESA-N","drugType":"Unknown","blackBoxWarning":false,"name":"MEPARTRICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipertrofan","Mepartricin","Methylpartricin","NSC-760091","Orofungin","SN 654","SN-654","SPA-S-160","Tricandil","Tricangine"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4091374","canonicalSmiles":"O=C(O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1ccc2ncsc2c1","inchiKey":"OQDQIFQRNZIEEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANIFIBRANOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IVA-337","IVA337","Iva337","Lanifibranor"],"crossReferences":{"drugbank":["DB14801"]},"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_0000404","EFO_0003095","EFO_1001249"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL41342","canonicalSmiles":"CC(C)=CCC/C(C)=C/COP(=O)(O)OP(=O)(O)O","inchiKey":"GVVPGTZRZFNKDS-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GERANYL DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Geranyl Diphosphate"],"crossReferences":{"Wikipedia":["Geranyl_pyrophosphate"],"drugbank":["DB02552"],"chEBI":["17211"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297142","canonicalSmiles":"CC(=O)O.CC(=O)O.CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O","inchiKey":"OGUJBRYAAJYXQP-LLXMLGLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASPOFUNGIN ACETATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL499808","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cancidas","Caspofungin acetate"],"synonyms":["Caspofungin acetate","Caspofungin diacetate","MK-0991"],"crossReferences":{"DailyMed":["caspofungin%20acetate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL4297364","canonicalSmiles":"CC[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"NVOYVOBDTVTBDX-AGUVMIOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXITROPIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxitropium"],"childChemblIds":["CHEMBL4297109"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for airway obstruction and has 1 investigational indication."}
{"id":"CHEMBL4297482","canonicalSmiles":"Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13","inchiKey":"KBQCEQAXHPIRTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-5991","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5991","AZD5991","Azd 5991","Azd-5991","Azd5991"],"crossReferences":{"drugbank":["DB14792"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297510","canonicalSmiles":"O=C(NCCS)c1cccc(C(=O)NCCS)c1","inchiKey":"JUTBAVRYDAKVGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMERAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emeramide"],"crossReferences":{"drugbank":["DB12192"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297859","drugType":"Antibody","blackBoxWarning":false,"name":"AZINTUXIZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abbv-838","Azintuxizumab vedotin"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000026751","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297889","drugType":"Unknown","blackBoxWarning":false,"name":"AVACINCAPTAD PEGOL SODIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARC-1905","ARC1905","Arc1905","Avacincaptad pegol sodium"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297948","drugType":"Unknown","blackBoxWarning":false,"name":"ERY-974","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ERY-974","ERY974","Ery-974","Ery974"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297953","drugType":"Unknown","blackBoxWarning":false,"name":"ANTI-INHIBITOR COAGULANT COMPLEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti inhibitor coagulant complex","Anti-inhibitor coagulant complex","Antiinhibitor coagulant complex","Factor viii bypassing fraction","Factor viii inhibitor bypassing fraction","Feiba"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298006","drugType":"Antibody","blackBoxWarning":false,"name":"ENVAFOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASC-22","ASC22","Asc22","Envafolimab","KN-035","KN035","Kn 035","Kn035"],"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003891","EFO_0000503","MONDO_0021117","EFO_0000764","MONDO_0011962","EFO_0000182","EFO_1000657","MONDO_0007254","EFO_0003060","EFO_0004239"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298036","drugType":"Unknown","blackBoxWarning":false,"name":"CURCUMINOIDS","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Curcuminoids","Meriva","Norflo oro"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298117","drugType":"Antibody","blackBoxWarning":false,"name":"ORILANOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALXN-1830","ALXN1830","Alxn1830","Orilanolimab","SYNT-001","SYNT001","SYNT1001","Synt001"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298176","drugType":"Antibody","blackBoxWarning":false,"name":"GARETOSMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Garetosmab","REGN-2477","REGN2477"],"linkedTargets":{"rows":["ENSG00000122641"],"count":1},"linkedDiseases":{"rows":["EFO_0007323","Orphanet_337"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4466233","canonicalSmiles":"CC(=O)N1CCC(Nc2cc(C(=O)NC[C@H](O)CN3CCc4ccccc4C3)ncn2)CC1","inchiKey":"JLCCNYVTIWRPIZ-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMRAMETOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPZ015938","GSK3326595","Gsk 3326595","Gsk-3326595","Gsk3326595","Pemrametostat"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594348","canonicalSmiles":"C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1","inchiKey":"UNHZLHSLZZWMNP-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELSUBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-105","ABBV105","Elsubrutinib"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594554","drugType":"Antibody","blackBoxWarning":false,"name":"TAFOLECIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IBI-306","IBI306","Ibi306","Tafolecimab"],"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["HP_0003124","Orphanet_391665","EFO_0004911"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594589","drugType":"Unknown","blackBoxWarning":false,"name":"RETINOIC ACID RECEPTOR .GAMMA.","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rar gamma","Retinoic acid receptor .gamma."],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650421","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT HUMAN INTERLEUKIN-15","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recombinant human il-15","Recombinant human interleukin-15","Rhil-15"],"linkedTargets":{"rows":["ENSG00000134470"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000681","EFO_0000311"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL47405","canonicalSmiles":"O=C(Cn1ccnc1[N+](=O)[O-])NCCO","inchiKey":"WCDWBPCFGJXFJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETANIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Radinyl"],"synonyms":["Etanidazole","NSC-301467","SR 2508","SR-2508"],"crossReferences":{"PubChem":["11112677","144204150","148250","170466603","26749865"],"Wikipedia":["Etanidazole"],"drugbank":["DB12736"],"chEBI":["75473"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478649","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1","inchiKey":"BOPSUAHGQHFKGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07835"],"chEBI":["90527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802210","drugType":"Antibody","blackBoxWarning":false,"name":"BEBTELOVIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bebtelovimab","LY-3853113","LY-CoV1404","LY3853113","Ly3853113"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL493737","canonicalSmiles":"CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"DSCFFEYYQKSRSV-KLJZZCKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLINOSITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-o-methyl-d-chiro-inositol","Cathrtomannitol","D-3-o-methyl-chiro-inositol","D-chiro-inositol, 3-o-methyl-","D-pinitol","Inositol, 3-o-methyl-, d-chiro-","Inzitol","Matezit","Methylinositol","NDI 18","NIC5-15","NSC-128700","Nic5-15","Piniol","Pinitol","Pinitol b"],"crossReferences":{"Wikipedia":["Pinitol"],"drugbank":["DB12969"],"chEBI":["28548"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL53929","canonicalSmiles":"NCC(O)c1ccc(O)cc1","inchiKey":"QHGUCRYDKWKLMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTOPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ND 50","ND-50","NSC-757399","Octopamine"],"crossReferences":{"PubChem":["104171205","144203766","170465959","90341287"],"Wikipedia":["Octopamine"],"drugbank":["DB13251"],"chEBI":["17134"]},"childChemblIds":["CHEMBL1367565"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL574003","canonicalSmiles":"c1ccc(C(OC2CCN(CCCc3nnn[nH]3)CC2)c2ccccc2)cc1","inchiKey":"TZQGXAHOROZEKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HQL-79","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HQL-79"],"crossReferences":{"drugbank":["DB07917"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL629","canonicalSmiles":"CN(C)CCC=C1c2ccccc2CCc2ccccc21","inchiKey":"KRMDCWKBEZIMAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMITRIPTYLINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amitid","Amitril","Amitriptyline","Damitriptyline","Elavil","Endep","Etrafon-A","Etrafon-Forte","Flavyl","Laroxyl","Limbitrol","Proheptadiene","Seroten","Triptanol"],"crossReferences":{"DailyMed":["amitriptyline%20hydrochloride"],"PubChem":["11110782","11110783","124879280","90340850"],"TG-GATEs":["70"],"Wikipedia":["Amitriptyline"],"drugbank":["DB00321"],"chEBI":["2666"]},"childChemblIds":["CHEMBL1200964"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005687","HP_0000989","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0008507","EFO_0004698","MONDO_0005277","MONDO_0002050","EFO_0004244","EFO_0003761","EFO_1000632","EFO_0005230","EFO_0000400","EFO_0005762","EFO_0006859","HP_0012532","EFO_0009387","EFO_0003843","HP_0002315","EFO_1000941","EFO_0007169","EFO_0010282","EFO_0000512","HP_0030833","EFO_0004149","EFO_1001800"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for depressive disorder and unipolar depression and has 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL707","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC","inchiKey":"RUZYUOTYCVRMRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAZOSIN","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C02CA04","Cardura","Doxazosin","UK-33274"],"crossReferences":{"DailyMed":["doxazosin%20mesylate"],"PubChem":["124883384","50105246","90341261"],"Wikipedia":["Doxazosin"],"drugbank":["DB00590"],"chEBI":["4708"]},"childChemblIds":["CHEMBL1200561"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003777","EFO_0002610","HP_0003124","EFO_0004234","EFO_0000401","EFO_0003768","EFO_0000284","EFO_0001358","EFO_0009094","EFO_0000537","EFO_0003890","MONDO_0002491","EFO_1001375","EFO_0003144","EFO_0004253","EFO_0000612","MONDO_0007079","EFO_0000400","EFO_0000239"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved and 17 investigational indications."}
{"id":"CHEMBL77675","canonicalSmiles":"N=C(Nc1ccccc1)Nc1ccccc1","inchiKey":"OWRCNXZUPFZXOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N,N'-Diphenyl-Guanidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N,N'-Diphenyl-Guanidine"],"crossReferences":{"PubChem":["144204549","144214002","170465656","17389460","26752749","49671529","49826097"],"drugbank":["DB14191"]},"childChemblIds":["CHEMBL556117"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL864","canonicalSmiles":"CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1","inchiKey":"OJFSXZCBGQGRNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBINOXAMINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbinoxamine","Clistin","Palgic"],"crossReferences":{"DailyMed":["carbinoxamine%20maleate"],"PubChem":["29217899"],"Wikipedia":["Carbinoxamine"],"drugbank":["DB00748"],"chEBI":["3398"]},"childChemblIds":["CHEMBL1200974","CHEMBL1519829"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007533","MONDO_0005271","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003956"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 7 approved indications."}
{"id":"CHEMBL88153","canonicalSmiles":"COc1ccc(C(CC(N)=O)N2C(=O)c3ccccc3C2=O)cc1OC1CCCC1","inchiKey":"DDYUBCCTNHWSQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CDC-801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-1088","CDC-801","CDC801","Cdc-801"],"crossReferences":{"drugbank":["DB15640"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL894","canonicalSmiles":"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1","inchiKey":"SNPPWIUOZRMYNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPROPION","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amfebutamone","Bupropion","Bupropion extended release","Bupropion slow release","NSC-758686"],"crossReferences":{"DailyMed":["bupropion%20hydrobromide","bupropion%20hydrochloride"],"PubChem":["174006913","90340803"],"Wikipedia":["Bupropion"],"drugbank":["DB01156"],"chEBI":["3219"]},"childChemblIds":["CHEMBL1698","CHEMBL1201735"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0004320","MONDO_0005090","EFO_0002610","MONDO_0002009","Orphanet_905","HP_0000726","EFO_0003768","EFO_0004318","EFO_0007191","Orphanet_68380","MONDO_0002046","EFO_0004247","EFO_0004714","MONDO_0002050","EFO_0000289","MONDO_0008903","EFO_0003761","EFO_0009854","EFO_0004701","MONDO_0007079","EFO_0005230","EFO_0002617","EFO_0000616","EFO_0004319","EFO_0003888","EFO_0006859","EFO_0005203","EFO_0001074","EFO_0009963","EFO_0000313","EFO_0001073","EFO_0000384","Orphanet_95","MONDO_0008315","EFO_0003060","Orphanet_399","EFO_0008623","EFO_0003890","MONDO_0002491","EFO_0000095","MONDO_0004975","EFO_0004270","MONDO_0005148","EFO_0005411"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 35 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL94454","canonicalSmiles":"CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1","inchiKey":"PVLJETXTTWAYEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIZOLASTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mizollen"],"synonyms":["Mizolastine"],"crossReferences":{"PubChem":["144206216","170465604","50125752"],"Wikipedia":["Mizolastine"],"drugbank":["DB12523"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergic disease."}
{"id":"CHEMBL947","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21","inchiKey":"GECBBEABIDMGGL-RTBURBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CESAMET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nabilone"],"crossReferences":{"Wikipedia":["Nabilone"],"drugbank":["DB00486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
